Granite FO LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Granite FO LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$245K	Hold	1,550	–	–	0.13%	40
2026 Q1	$198K	Hold	1,550	–	–	0.12%	46
2025 Q4	$189K	Hold	1,550	–	–	0.1%	52
2025 Q3	$155K	Hold	1,550	–	–	0.08%	58
2025 Q2	$129K	Hold	1,550	–	–	0.07%	60
2025 Q1	$126K	Hold	1,550	–	–	0.07%	60
2024 Q4	$140K	Hold	1,550	–	–	0.08%	60
2024 Q3	$153K	Sell	1,550 -850	-35%	-$83.5K	0.09%	59
2024 Q2	$223K	Hold	2,400	–	–	0.14%	48
2024 Q1	$241K	Buy	2,400 +1,700	+243%	+$158K	0.14%	47
2023 Q4	$62.5K	Hold	700	–	–	0.04%	94
2023 Q3	$51.1K	Hold	700	–	–	0.04%	102
2023 Q2	$58.2K	Sell	700 -1,150	-62%	-$96.2K	0.04%	109
2023 Q1	$148K	Buy	+1,850	New	+$154K	0.09%	88

Other funds holding XBI

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

NHFG

New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return

RAM

Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

Granite FO LLC's XBI Position: Q2 2026 in Review

Granite FO LLC held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 1,550 shares worth $245K. The position accounts for 0.13% of the portfolio, ranked #40.

Granite FO LLC first reported a position in XBI in Q1 2023 and has held it in 14 quarters since. 393 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Granite FO LLC held 1,550 shares of State Street SPDR S&P Biotech ETF worth $245K as of Q2 2026.
Granite FO LLC left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.13% of Granite FO LLC's portfolio in Q2 2026, its #40 holding.
Granite FO LLC first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and has held it in 14 quarters since.
393 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Granite FO LLC's 13F filing for Q2 2026, filed 15 Jul 2026.